Knowledge, awareness and utilisation of the human papillomavirus vaccine in Durban

IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Southern African Journal of Gynaecological Oncology Pub Date : 2012-01-01 DOI:10.1080/20742835.2012.11441185
N. Allie, M. Moodley
{"title":"Knowledge, awareness and utilisation of the human papillomavirus vaccine in Durban","authors":"N. Allie, M. Moodley","doi":"10.1080/20742835.2012.11441185","DOIUrl":null,"url":null,"abstract":"Abstract Background: Human papillomavirus (HPV) is the causative agent of cervical cancers, low-grade cervical lesions, and warts of the genital tract. Since March 2008, a vaccine against HPV has been licensed for use in South Africa to reduce the incidence of HPV. The rationale for undertaking this research project was to establish the knowledge, awareness, and utilisation, of the HPV vaccine, among different healthcare workers. Method: Healthcare providers (100 general practitioners, 50 gynaecologists, 50 paediatricians, 50 medical staff and 50 nurses) working in the private sector, in the Ethekweni health district in KwaZulu-Natal, were interviewed. Comparisons of awareness among subgroups of healthcare providers were analysed. Associations between awareness and other factors were tested using a chi-square test. Results: Awareness of the vaccine was found to be 89% among healthcare workers,while 70.4% of practitioners informed patients of the availability of the HPV vaccine. Most practitioners (77.9%) have only prescribed the vaccine less than ten times. Gardasil® was prescribed by 46% of healthcare workers. In general, practitioners were unaware that Gardasil® could be prescribed to males (62.9%). Conclusion: Healthcare workers were aware of the HPV vaccine, and prescribed it on request. However, even though practitioners were aware of it, most prescribed it less than 10 times since it was licensed. Knowledge regarding the vaccine is deficient, as practitioners are unaware of its licensed use.","PeriodicalId":41638,"journal":{"name":"Southern African Journal of Gynaecological Oncology","volume":"37 1","pages":"10 - 6"},"PeriodicalIF":0.1000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/20742835.2012.11441185","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Southern African Journal of Gynaecological Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20742835.2012.11441185","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Abstract Background: Human papillomavirus (HPV) is the causative agent of cervical cancers, low-grade cervical lesions, and warts of the genital tract. Since March 2008, a vaccine against HPV has been licensed for use in South Africa to reduce the incidence of HPV. The rationale for undertaking this research project was to establish the knowledge, awareness, and utilisation, of the HPV vaccine, among different healthcare workers. Method: Healthcare providers (100 general practitioners, 50 gynaecologists, 50 paediatricians, 50 medical staff and 50 nurses) working in the private sector, in the Ethekweni health district in KwaZulu-Natal, were interviewed. Comparisons of awareness among subgroups of healthcare providers were analysed. Associations between awareness and other factors were tested using a chi-square test. Results: Awareness of the vaccine was found to be 89% among healthcare workers,while 70.4% of practitioners informed patients of the availability of the HPV vaccine. Most practitioners (77.9%) have only prescribed the vaccine less than ten times. Gardasil® was prescribed by 46% of healthcare workers. In general, practitioners were unaware that Gardasil® could be prescribed to males (62.9%). Conclusion: Healthcare workers were aware of the HPV vaccine, and prescribed it on request. However, even though practitioners were aware of it, most prescribed it less than 10 times since it was licensed. Knowledge regarding the vaccine is deficient, as practitioners are unaware of its licensed use.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
德班人乳头瘤病毒疫苗的知识、认识和利用情况
背景:人乳头瘤病毒(HPV)是宫颈癌、低级别宫颈病变和生殖道疣的病原体。自2008年3月以来,一种针对人乳头瘤病毒的疫苗已获准在南非使用,以减少人乳头瘤病毒的发病率。开展这项研究项目的基本原理是在不同的卫生保健工作者中建立人乳头瘤病毒疫苗的知识、意识和利用。方法:对夸祖鲁-纳塔尔省Ethekweni卫生区私营部门的保健提供者(100名全科医生、50名妇科医生、50名儿科医生、50名医务人员和50名护士)进行了访谈。比较医疗保健提供者亚组之间的意识进行了分析。意识与其他因素之间的关联采用卡方检验。结果:89%的卫生保健工作者了解HPV疫苗,而70.4%的从业人员告知患者HPV疫苗的可用性。大多数从业人员(77.9%)只开过不到10次疫苗。46%的医护人员开了加德西。总的来说,从业者不知道加德西®可以开给男性(62.9%)。结论:卫生保健工作者了解HPV疫苗,并根据要求开处方。然而,即使从业人员知道它,自它获得许可以来,大多数人开出的处方还不到10次。关于疫苗的知识不足,因为从业人员不知道其许可使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
24 weeks
期刊最新文献
Retrospective review of 37.4 Gy in 11 fractions for the palliation of advanced cervical cancer Challenges managing women with suspected Lynch Syndrome in Zimbabwe: a case report A retrospective study comparing the efficiency of recurrent LSIL cytology to high-grade cytology as predictors of high-grade cervical intraepithelial neoplasia or worse (CIN2+) A retrospective study of the epidemiology and histological subtypes of ovarian epithelial neoplasms at Charlotte Maxeke Johannesburg Academic Hospital Laparoscopic inguinal lymph node dissection in carcinoma of the vulva: experience and intermediate results at one institution
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1